First Affirmative Financial Network boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 12.5% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,172 shares of the healthcare conglomerate’s stock after purchasing an additional 241 shares during the quarter. UnitedHealth Group accounts for about 1.1% of First Affirmative Financial Network’s investment portfolio, making the stock its 13th biggest holding. First Affirmative Financial Network’s holdings in UnitedHealth Group were worth $1,108,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. State Street Corp lifted its stake in UnitedHealth Group by 1.9% in the fourth quarter. State Street Corp now owns 45,559,868 shares of the healthcare conglomerate’s stock valued at $22,877,432,000 after buying an additional 869,827 shares in the last quarter. Capital International Investors lifted its stake in UnitedHealth Group by 4.3% in the fourth quarter. Capital International Investors now owns 19,342,468 shares of the healthcare conglomerate’s stock valued at $9,713,058,000 after buying an additional 790,219 shares in the last quarter. Geode Capital Management LLC lifted its stake in UnitedHealth Group by 1.2% in the fourth quarter. Geode Capital Management LLC now owns 15,618,069 shares of the healthcare conglomerate’s stock valued at $7,821,210,000 after buying an additional 189,864 shares in the last quarter. Alliancebernstein L.P. lifted its stake in UnitedHealth Group by 2.4% in the fourth quarter. Alliancebernstein L.P. now owns 11,015,163 shares of the healthcare conglomerate’s stock valued at $5,531,154,000 after buying an additional 257,910 shares in the last quarter. Finally, Norges Bank bought a new stake in shares of UnitedHealth Group in the fourth quarter worth $4,478,185,000. Hedge funds and other institutional investors own 87.48% of the company’s stock.
A number of brokerages have recently commented on UNH. Barclays boosted their price objective on shares of UnitedHealth Group from $495.00 to $565.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 30th. Truist Financial boosted their price objective on shares of UnitedHealth Group from $575.00 to $610.00 in a research report on Thursday, April 7th. Loop Capital initiated coverage on shares of UnitedHealth Group in a report on Thursday, June 16th. They set a “buy” rating and a $575.00 target price on the stock. Credit Suisse Group boosted their target price on shares of UnitedHealth Group from $564.00 to $595.00 and gave the stock an “outperform” rating in a report on Monday, April 18th. Finally, SVB Leerink boosted their target price on shares of UnitedHealth Group from $550.00 to $600.00 and gave the stock an “outperform” rating in a report on Tuesday, April 19th. Three research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $555.73.
UnitedHealth Group (NYSE:UNH – Get Rating) last posted its quarterly earnings data on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share for the quarter, topping the consensus estimate of $5.40 by $0.09. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. The business had revenue of $80.15 billion during the quarter, compared to analysts’ expectations of $78.77 billion. During the same quarter in the prior year, the business posted $5.31 earnings per share. UnitedHealth Group’s revenue was up 14.2% compared to the same quarter last year. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 21.75 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 28th. Investors of record on Monday, June 20th will be given a dividend of $1.65 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. The ex-dividend date of this dividend is Thursday, June 16th. This represents a $6.60 annualized dividend and a yield of 1.35%. UnitedHealth Group’s dividend payout ratio is currently 36.12%.
In other news, Director Richard T. Burke sold 2,500 shares of the stock in a transaction dated Thursday, May 19th. The shares were sold at an average price of $478.96, for a total value of $1,197,400.00. Following the completion of the transaction, the director now owns 1,215,000 shares of the company’s stock, valued at $581,936,400. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Frederick William Mcnabb III bought 89 shares of the company’s stock in a transaction dated Thursday, May 26th. The stock was bought at an average cost of $504.32 per share, with a total value of $44,884.48. Following the acquisition, the director now directly owns 11,259 shares of the company’s stock, valued at approximately $5,678,138.88. The disclosure for this purchase can be found here. Corporate insiders own 0.40% of the company’s stock.
UnitedHealth Group Company Profile (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Victoria’s Secret Stock is Out of the Box
- Downturn Gives These 3 Buys Juicy Dividend Yields
- Time For a Ride in Six Flags Stock
- Why Dollar General (NYSE: DG) Should Be In Your Portfolio
- Korn Ferry Is A Good Buy For The Recession And Beyond
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.